$DCTH
Delcath Systems Inc

2022 Q4 Form 10-Q Financial Statement

#000119312522280207 Filed on November 08, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $639.0K $906.0K $522.0K
YoY Change -69.69% 73.56% 11.06%
Cost Of Revenue $237.0K $235.0K $227.0K
YoY Change 82.31% 3.52% 19.47%
Gross Profit $402.0K $671.0K $295.0K
YoY Change -79.68% 127.46% 5.36%
Gross Profit Margin 62.91% 74.06% 56.51%
Selling, General & Admin $4.994M $4.519M $4.036M
YoY Change 65.58% 11.97% 101.8%
% of Gross Profit 1242.29% 673.47% 1368.14%
Research & Development $4.934M $3.953M $2.955M
YoY Change 36.34% 33.77% -9.36%
% of Gross Profit 1227.36% 589.12% 1001.69%
Depreciation & Amortization $34.00K $67.00K $37.00K
YoY Change 9.68% 81.08% -7.5%
% of Gross Profit 8.46% 9.99% 12.54%
Operating Expenses $9.928M $8.472M $6.991M
YoY Change 49.63% 21.18% 32.91%
Operating Profit -$9.526M -$7.801M -$6.696M
YoY Change 104.55% 16.5% 34.46%
Interest Expense -$645.0K -$730.0K -$420.0K
YoY Change -5.84% 73.81% 950.0%
% of Operating Profit
Other Income/Expense, Net $28.00K $26.00K -$9.000K
YoY Change -660.0% -388.89% -127.27%
Pretax Income -$10.14M -$8.505M -$7.125M
YoY Change 89.7% 19.37% 42.79%
Income Tax
% Of Pretax Income
Net Earnings -$10.14M -$8.505M -$7.125M
YoY Change 89.7% 19.37% 42.76%
Net Earnings / Revenue -1587.32% -938.74% -1364.94%
Basic Earnings Per Share -$0.92 -$0.94
Diluted Earnings Per Share -$1.03 -$0.92 -$939.0K
COMMON SHARES
Basic Shares Outstanding 8.598M 8.598M 7.588M
Diluted Shares Outstanding 9.216M 7.588M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.671M $9.831M $24.87M
YoY Change -66.36% -60.46% 128.12%
Cash & Equivalents $7.671M $9.831M $24.87M
Short-Term Investments $0.00
Other Short-Term Assets $6.120M $6.186M $6.146M
YoY Change -11.23% 0.65% 201.27%
Inventory $1.998M $1.926M $1.238M
Prepaid Expenses
Receivables $366.0K $537.0K $69.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $16.16M $18.48M $32.32M
YoY Change -48.14% -42.82% 132.84%
LONG-TERM ASSETS
Property, Plant & Equipment $1.422M $1.452M $1.380M
YoY Change 5.49% 5.22% -42.98%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.707M $1.746M $2.107M
YoY Change -13.44% -17.13% -21.67%
TOTAL ASSETS
Total Short-Term Assets $16.16M $18.48M $32.32M
Total Long-Term Assets $1.707M $1.746M $2.107M
Total Assets $17.86M $20.23M $34.43M
YoY Change -46.08% -41.25% 107.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.018M $2.632M $1.187M
YoY Change 216.3% 121.74% -20.87%
Accrued Expenses $4.685M $5.137M $3.269M
YoY Change 14.02% 57.14% -50.77%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $7.846M $6.481M $0.00
YoY Change 1163.45% -100.0%
Total Short-Term Liabilities $14.74M $14.45M $5.361M
YoY Change 147.48% 169.46% -49.61%
LONG-TERM LIABILITIES
Long-Term Debt $7.842M $9.727M $15.44M
YoY Change -47.76% -36.98%
Other Long-Term Liabilities $1.144M $1.299M $1.902M
YoY Change 452.66% -31.7% -28.23%
Total Long-Term Liabilities $1.144M $1.299M $17.34M
YoY Change -92.48% -92.51% 554.26%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.74M $14.45M $5.361M
Total Long-Term Liabilities $1.144M $1.299M $17.34M
Total Liabilities $23.72M $25.47M $22.70M
YoY Change 12.04% 12.22% 70.81%
SHAREHOLDERS EQUITY
Retained Earnings -$457.5M -$447.3M -$415.6M
YoY Change 8.67% 7.62%
Common Stock $100.0K $86.00K $74.00K
YoY Change 26.58% 16.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.859M -$5.246M $11.73M
YoY Change
Total Liabilities & Shareholders Equity $17.86M $20.23M $34.43M
YoY Change -46.08% -41.25% 107.75%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$10.14M -$8.505M -$7.125M
YoY Change 89.7% 19.37% 42.76%
Depreciation, Depletion And Amortization $34.00K $67.00K $37.00K
YoY Change 9.68% 81.08% -7.5%
Cash From Operating Activities -$7.359M -$5.179M -$4.524M
YoY Change 14.79% 14.48% -12.83%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$68.00K -$56.00K
YoY Change -100.0% 21.43% -88.57%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$68.00K -$56.00K
YoY Change -100.0% 21.43% -88.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.247M 4.896M 14.12M
YoY Change 21.77% -65.33% 2039.39%
NET CHANGE
Cash From Operating Activities -7.359M -5.179M -4.524M
Cash From Investing Activities 0.000 -68.00K -56.00K
Cash From Financing Activities 5.247M 4.896M 14.12M
Net Change In Cash -2.112M -351.0K 9.540M
YoY Change 0.52% -103.68% -290.04%
FREE CASH FLOW
Cash From Operating Activities -$7.359M -$5.179M -$4.524M
Capital Expenditures $0.00 -$68.00K -$56.00K
Free Cash Flow -$7.359M -$5.111M -$4.468M
YoY Change 14.77% 14.39% -4.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000872912
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-16133
dei Entity Registrant Name
EntityRegistrantName
DELCATH SYSTEMS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
06-1245881
dei Entity Address Address Line1
EntityAddressAddressLine1
1633 Broadway
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 22C
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10019
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
489-2100
dei Security12b Title
Security12bTitle
Common stock, $0.01 par value per share
dei Trading Symbol
TradingSymbol
DCTH
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 us-gaap Inventory Net
InventoryNet
1412000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2035000
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8597682
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9831000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22802000
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
4151000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
4151000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
537000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
44000
CY2022Q3 us-gaap Inventory Net
InventoryNet
1926000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2743000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
18480000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
31152000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1452000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1348000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
294000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
624000
CY2022Q3 us-gaap Assets
Assets
20226000
CY2021Q4 us-gaap Assets
Assets
33124000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2632000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
638000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5137000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4109000
CY2022Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
170000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
196000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
416000
CY2022Q3 us-gaap Loans Payable Current
LoansPayableCurrent
6481000
CY2021Q4 us-gaap Loans Payable Current
LoansPayableCurrent
621000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
14446000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5954000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1299000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
207000
CY2022Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
4990000
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
10372000
CY2022Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
4737000
CY2021Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
4639000
CY2022Q3 us-gaap Liabilities
Liabilities
25472000
CY2021Q4 us-gaap Liabilities
Liabilities
21172000
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
11357
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
11357
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
11357
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8597682
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
11357
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8597682
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7906728
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7906728
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
86000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
79000
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
442066000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
432831000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-447341000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-420976000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-57000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
18000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-5246000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
11952000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20226000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
33124000
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
235000
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
227000
us-gaap Cost Of Revenue
CostOfRevenue
449000
us-gaap Cost Of Revenue
CostOfRevenue
541000
CY2022Q3 us-gaap Gross Profit
GrossProfit
671000
CY2021Q3 us-gaap Gross Profit
GrossProfit
295000
us-gaap Gross Profit
GrossProfit
1631000
us-gaap Gross Profit
GrossProfit
906000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3953000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2955000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13649000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10159000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4519000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4036000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12309000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10621000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
8472000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
6991000
us-gaap Operating Expenses
OperatingExpenses
25958000
us-gaap Operating Expenses
OperatingExpenses
20780000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7801000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6696000
us-gaap Operating Income Loss
OperatingIncomeLoss
-24327000
us-gaap Operating Income Loss
OperatingIncomeLoss
-19874000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2040000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-501000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-82000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
26000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
73000
CY2022Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-730000
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-420000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
84000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8551000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7074000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-46000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
51000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-8505000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-7125000
us-gaap Net Income Loss
NetIncomeLoss
-26365000
us-gaap Net Income Loss
NetIncomeLoss
-20302000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26447000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20218000
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.92
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.92
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.94
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.94
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.93
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.93
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9215786
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9215786
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7587643
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7587643
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8536006
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8536006
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6923541
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6923541
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
11952000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1474000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-8203000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
5225000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1617000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-9657000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-31000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-2846000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1255000
CY2022Q3 dcth Issuance Of Common Stock And Pre Funded Warrants In Private Placement
IssuanceOfCommonStockAndPreFundedWarrantsInPrivatePlacement
4896000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-8505000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-46000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-5246000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
22078000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
2148000
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
57000
CY2021Q1 dcth Stock Issued During Period Value Exchange Of Warrants For Common Stock
StockIssuedDuringPeriodValueExchangeOfWarrantsForCommonStock
2376000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-6747000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
94000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
20006000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1626000
CY2021Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1000
CY2021Q2 dcth Stock Issued During Period Value Exchange Of Warrants For Common Stock
StockIssuedDuringPeriodValueExchangeOfWarrantsForCommonStock
17000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-6430000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-61000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
15159000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
2449000
us-gaap Depreciation
Depreciation
98000
us-gaap Depreciation
Depreciation
115000
CY2021Q3 dcth Proceeds From Warrant
ProceedsFromWarrant
-1171000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
44000
CY2021Q3 dcth Stock Issued During Period Value Exchange Of Warrants For Common Stock
StockIssuedDuringPeriodValueExchangeOfWarrantsForCommonStock
65000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-7125000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
51000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
11726000
us-gaap Net Income Loss
NetIncomeLoss
-26365000
us-gaap Net Income Loss
NetIncomeLoss
-20302000
dcth Stock Option Compensation Income Expense
StockOptionCompensationIncomeExpense
4345000
dcth Stock Option Compensation Income Expense
StockOptionCompensationIncomeExpense
6224000
dcth Amortization Of Right Of Use Assets
AmortizationOfRightOfUseAssets
339000
dcth Amortization Of Right Of Use Assets
AmortizationOfRightOfUseAssets
0
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
574000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
127000
us-gaap Paid In Kind Interest
PaidInKindInterest
120000
us-gaap Paid In Kind Interest
PaidInKindInterest
119000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-708000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-676000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
493000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
515000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
383000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2907000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2622000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
861000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
0
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-170000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-517000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17591000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16575000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
209000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
144000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-209000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-144000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
4896000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0
dcth Net Proceeds From Debt Financing
NetProceedsFromDebtFinancing
0
dcth Net Proceeds From Debt Financing
NetProceedsFromDebtFinancing
14437000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2458000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4896000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16895000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-67000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
84000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12971000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
260000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26953000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
28756000
us-gaap Interest Paid Net
InterestPaidNet
260000
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
0
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
9000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13982000
dcth Shares Settled For Services
SharesSettledForServices
0
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
29016000
CY2022Q3 us-gaap Cash
Cash
9831000
dcth Shares Settled For Services
SharesSettledForServices
57000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2035000
CY2021Q3 us-gaap Cash
Cash
24865000
CY2022Q3 us-gaap Restricted Cash
RestrictedCash
4151000
CY2021Q3 us-gaap Restricted Cash
RestrictedCash
4151000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13982000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
29016000
us-gaap Interest Paid Net
InterestPaidNet
1337000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
192000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-447300000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Reclassifications </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Certain prior period balances have been reclassified in order to conform to current period presentation. These reclassifications have no effect on previously reported results of operations or loss per share. </div></div>
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2743000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9831000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22802000
CY2022Q3 dcth Loan Agreement Restricted Cash
LoanAgreementRestrictedCash
4000000
CY2021Q4 dcth Loan Agreement Restricted Cash
LoanAgreementRestrictedCash
4000000
CY2022Q3 dcth Letters Of Credit Restricted Cash
LettersOfCreditRestrictedCash
101000
CY2021Q4 dcth Letters Of Credit Restricted Cash
LettersOfCreditRestrictedCash
101000
CY2022Q3 dcth Security For Credit Cards Restricted Cash
SecurityForCreditCardsRestrictedCash
50000
CY2021Q4 dcth Security For Credit Cards Restricted Cash
SecurityForCreditCardsRestrictedCash
50000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13982000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26953000
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
208000
CY2022Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
810000
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
767000
CY2022Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
1014000
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
645000
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
102000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
0
CY2022Q3 us-gaap Inventory Net
InventoryNet
1926000
CY2021Q4 us-gaap Inventory Net
InventoryNet
1412000
CY2022Q3 dcth Prepaid Clinical Trial Expenses Current
PrepaidClinicalTrialExpensesCurrent
1630000
CY2021Q4 dcth Prepaid Clinical Trial Expenses Current
PrepaidClinicalTrialExpensesCurrent
1630000
CY2022Q3 us-gaap Prepaid Insurance
PrepaidInsurance
158000
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
890000
CY2022Q3 dcth Prepaid Professional Services Current
PrepaidProfessionalServicesCurrent
210000
CY2021Q4 dcth Prepaid Professional Services Current
PrepaidProfessionalServicesCurrent
15000
CY2022Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
37000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5137000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4109000
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6315000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6173000
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4863000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4825000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1452000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1348000
dcth Depreciation Expense
DepreciationExpense
98000
dcth Depreciation Expense
DepreciationExpense
115000
CY2022Q3 dcth Accrued Clinical Expenses Current
AccruedClinicalExpensesCurrent
2267000
CY2021Q4 dcth Accrued Clinical Expenses Current
AccruedClinicalExpensesCurrent
1517000
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1056000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
893000
CY2022Q3 dcth Short Term Fnancing
ShortTermFnancing
0
CY2021Q4 dcth Short Term Fnancing
ShortTermFnancing
551000
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1229000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
603000
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
513000
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
393000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
72000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
152000
CY2022Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P12M
us-gaap Operating Lease Cost
OperatingLeaseCost
339000
us-gaap Operating Lease Payments
OperatingLeasePayments
339000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
111000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
106000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
39000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
39000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
23000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
318000
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
24000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
294000
CY2022Q3 dcth Notes And Loans Payable Gross Non Current
NotesAndLoansPayableGrossNonCurrent
5498000
CY2022Q3 dcth Discount On Notes And Loans Payable Nonurrent
DiscountOnNotesAndLoansPayableNonurrent
-508000
CY2022Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
4990000
CY2021Q4 dcth Notes And Loans Payable Gross Non Current
NotesAndLoansPayableGrossNonCurrent
11924000
CY2021Q4 dcth Discount On Notes And Loans Payable Nonurrent
DiscountOnNotesAndLoansPayableNonurrent
-1552000
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
10372000
CY2022Q3 dcth Notes And Loans Payable Gross
NotesAndLoansPayableGross
5000000
CY2022Q3 dcth Discount On Notes And Loans Payable
DiscountOnNotesAndLoansPayable
-263000
CY2022Q3 dcth Notes And Loans Payable Net
NotesAndLoansPayableNet
4737000
CY2021Q4 dcth Notes And Loans Payable Gross
NotesAndLoansPayableGross
5000000
CY2021Q4 dcth Discount On Notes And Loans Payable
DiscountOnNotesAndLoansPayable
-361000
CY2021Q4 dcth Notes And Loans Payable Net
NotesAndLoansPayableNet
4639000
dcth Percentage Of Final Payment Included In Gross Amount
PercentageOfFinalPaymentIncludedInGrossAmount
0.0425
dcth Final Payment
FinalPayment
638000
CY2022Q3 us-gaap Loans Payable
LoansPayable
12638000
CY2022Q3 us-gaap Notes Payable
NotesPayable
5000000
CY2022Q3 us-gaap Notes And Loans Payable
NotesAndLoansPayable
17638000
CY2021Q3 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
150000
us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
1300000
dcth Avenue Warrant Value
AvenueWarrantValue
1300000
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y25D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.87
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0077
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
2475000
CY2020Q4 dcth Number Of Common Shares Remained Available To Be Issued
NumberOfCommonSharesRemainedAvailableToBeIssued
803105
us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.31
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.69
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1732460
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.69
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
650083
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.05
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
36628
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
10.44
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
95960
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
9.69
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2249955
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.46
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y4M24D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1143154
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
11.27
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y1M6D
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2249955
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y1M6D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1143154
CY2022Q3 dcth Share Based Compensation Income Expense
ShareBasedCompensationIncomeExpense
1255000
CY2021Q3 dcth Share Based Compensation Income Expense
ShareBasedCompensationIncomeExpense
2449000
dcth Share Based Compensation Income Expense
ShareBasedCompensationIncomeExpense
4346000
dcth Share Based Compensation Income Expense
ShareBasedCompensationIncomeExpense
6224000
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
6300000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y8M12D
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3894498
CY2021Q4 dcth Class Of Warrant Or Right Weighted Average Exercise Price
ClassOfWarrantOrRightWeightedAverageExercisePrice
9.27
dcth Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
566751
dcth Class Of Warrant Or Right Weighted Average Exercise Price Issued
ClassOfWarrantOrRightWeightedAverageExercisePriceIssued
0.01
dcth Class Of Warrant Or Right Exercises In Period
ClassOfWarrantOrRightExercisesInPeriod
0
dcth Class Of Warrant Or Right Weighted Average Exercise Price Exercises In Period
ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod
0
dcth Class Of Warrant Or Right Expired In Period
ClassOfWarrantOrRightExpiredInPeriod
0
dcth Class Of Warrant Or Right Weighted Average Exercise Price Expirations In Period
ClassOfWarrantOrRightWeightedAverageExercisePriceExpirationsInPeriod
0
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4461249
CY2022Q3 dcth Class Of Warrant Or Right Weighted Average Exercise Price
ClassOfWarrantOrRightWeightedAverageExercisePrice
8.09
dcth Class Of Warrant Or Right Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightWeightedAverageRemainingContractualTerm
P2Y9M18D
CY2022Q3 dcth Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
4461249
CY2022Q3 dcth Class Of Warrant Or Right Exercisable Weighted Average Exercise Price
ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice
8.09
dcth Class Of Warrant Or Right Exercisable Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightExercisableWeightedAverageRemainingContractualTerm
P2Y9M18D
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4461249
dcth Class Of Warrant Or Right Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightWeightedAverageRemainingContractualTerm
P2Y9M18D
CY2022Q3 dcth Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
4461249
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8334956
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7251510
dcth Number Of Shares Pre Funded Penny Warrants Outstanding
NumberOfSharesPreFundedPennyWarrantsOutstanding
850506
CY2022Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
8470006
CY2021Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
7354428
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
8096551
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
6665826
CY2022Q3 dcth Weighted Average Number Of Shares Pre Funded Warrants1
WeightedAverageNumberOfSharesPreFundedWarrants1
745780
CY2021Q3 dcth Weighted Average Number Of Shares Pre Funded Warrants1
WeightedAverageNumberOfSharesPreFundedWarrants1
233215
dcth Weighted Average Number Of Shares Pre Funded Warrants1
WeightedAverageNumberOfSharesPreFundedWarrants1
439455
dcth Weighted Average Number Of Shares Pre Funded Warrants1
WeightedAverageNumberOfSharesPreFundedWarrants1
257715
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9215786
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9215786
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7587643
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7587643
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8536006
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8536006
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6923541
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6923541
CY2022Q3 dcth Percentage Of Enrolled Patients
PercentageOfEnrolledPatients
0.87

Files In Submission

Name View Source Status
0001193125-22-280207-index-headers.html Edgar Link pending
0001193125-22-280207-index.html Edgar Link pending
0001193125-22-280207.txt Edgar Link pending
0001193125-22-280207-xbrl.zip Edgar Link pending
d319494d10q.htm Edgar Link pending
d319494dex311.htm Edgar Link pending
d319494dex312.htm Edgar Link pending
d319494dex321.htm Edgar Link pending
d319494dex322.htm Edgar Link pending
dcth-20220930.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
dcth-20220930_cal.xml Edgar Link unprocessable
dcth-20220930_def.xml Edgar Link unprocessable
dcth-20220930_lab.xml Edgar Link unprocessable
dcth-20220930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
d319494d10q_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending